Inovio Pharmaceuticals
INO
#8985
Rank
HK$0.93 B
Marketcap
HK$13.61
Share price
3.57%
Change (1 day)
-10.69%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): -HK$22.45

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$22.52. In 2024 the company made an earnings per share (EPS) of -HK$30.89 an increase over its 2023 EPS that were of -HK$47.62.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$22.45-27.33%
2024-HK$30.89-35.14%
2023-HK$47.62-56.62%
2022-HK$109.78-19.54%
2021-HK$136.4535.9%
2020-HK$100.40-11.57%
2019-HK$113.5315.24%
2018-HK$98.52-2.78%
2017-HK$101.346.93%
2016-HK$94.77134.88%
2015-HK$40.35-29.51%
2014-HK$57.24-57.34%
2013-HK$134.18146.55%
2012-HK$54.4220.83%
2011-HK$45.04-29.41%
2010-HK$63.80-48.48%
2009-HK$123.8610%
2008-HK$112.6011.11%
2007-HK$101.34-41.3%
2006-HK$172.65-66.91%
2005-HK$521.70110.61%
2004-HK$247.71-61.63%
2003-HK$645.55186.67%
2002-HK$225.19
2001N/A-100%
2000-HK$180.15-63.64%
1999-HK$495.43

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$87.09-486.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$57.55-355.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$10.63-147.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$50.98-326.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$57.13-353.71%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$29.46-230.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
-HK$9.77-56.60%๐Ÿ‡บ๐Ÿ‡ธ USA